ORGANON & CO. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.8 USD | +1.30% |
|
+6.76% | +51.18% |
| May. 08 | Organon Reports Pricing of $1 Billion Senior Notes Offering | MT |
| May. 08 | Organon & Co. and Organon Foreign Debt Co-Issuer B.V. Announces Pricing of $1.0 Billion Senior Notes Offering | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 7,721 | 7,104 | 3,686 | 5,606 | - | - |
| Enterprise Value (EV) 1 | 16,118 | 15,311 | 11,753 | 13,250 | 12,536 | 11,750 |
| P/E ratio | 5.73 x | 7.78 x | 3.61 x | 7.52 x | 5.81 x | 5.28 x |
| Yield | 1.84% | 4.01% | 7.77% | 5.1% | 5.3% | 5.14% |
| Capitalization / Revenue | 1.22 x | 1.15 x | 0.59 x | 0.88 x | 0.87 x | 0.86 x |
| EV / Revenue | 2.56 x | 2.48 x | 1.88 x | 2.07 x | 1.94 x | 1.8 x |
| EV / EBITDA | 6.77 x | 7.34 x | 6.05 x | 6.45 x | 5.96 x | 5.45 x |
| EV / FCF | 8.19 x | 23.1 x | 21.4 x | 16.6 x | 11.9 x | 10.5 x |
| FCF Yield | 12.2% | 4.32% | 4.66% | 6.01% | 8.37% | 9.54% |
| Price to Book | - | -7.99 x | -52.7 x | 10.9 x | 4.36 x | 2.56 x |
| Nbr of stocks (in thousands) | 253,550 | 254,364 | 255,606 | 257,171 | - | - |
| Reference price 2 | 30.45 | 27.93 | 14.42 | 21.80 | 21.80 | 21.80 |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 8,096 | 6,304 | 6,174 | 6,263 | 6,391 | 6,467 | 6,542 |
| EBITDA 1 | - | 2,379 | 2,085 | 1,944 | 2,055 | 2,105 | 2,155 |
| EBIT 1 | - | 2,184 | 1,873 | 1,874 | 1,930 | 1,979 | 2,031 |
| Operating Margin | - | 34.64% | 30.34% | 29.92% | 30.2% | 30.6% | 31.05% |
| Earnings before Tax (EBT) 1 | - | 1,529 | 1,122 | 673 | 933 | 1,252 | 1,418 |
| Net income 1 | 2,160 | 1,351 | 917 | 1,023 | 751 | 971 | 1,071 |
| Net margin | 26.68% | 21.43% | 14.85% | 16.33% | 11.75% | 15.01% | 16.37% |
| EPS 2 | - | 5.310 | 3.590 | 3.990 | 2.900 | 3.750 | 4.130 |
| Free Cash Flow 1 | - | 1,968 | 662 | 548 | 796.5 | 1,050 | 1,121 |
| FCF margin | - | 31.22% | 10.72% | 8.75% | 12.46% | 16.23% | 17.14% |
| FCF Conversion (EBITDA) | - | 82.72% | 31.75% | 28.19% | 38.75% | 49.87% | 52.04% |
| FCF Conversion (Net income) | - | 145.67% | 72.19% | 53.57% | 106.06% | 108.1% | 104.7% |
| Dividend per Share 2 | - | 0.5600 | 1.120 | 1.120 | 1.112 | 1.156 | 1.120 |
| Announcement Date | 4/14/21 | 2/17/22 | 2/16/23 | 2/15/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,604 | 1,567 | 1,585 | 1,537 | 1,485 | 1,538 | 1,608 | 1,519 | 1,598 | 1,622 | 1,627 | 1,556 | 1,573 | 1,570 | 1,609 |
| EBITDA 1 | 549 | 647 | 512 | 546 | 380 | 518 | 530 | 447 | 449 | 538 | 531 | 509 | 507 | - | - |
| EBIT 1 | 487 | 594 | 462 | 489 | 328 | 461 | 472 | 430 | 436 | 475 | 505.5 | 475.2 | 473.3 | 494.7 | 505 |
| Operating Margin | 30.36% | 37.91% | 29.15% | 31.82% | 22.09% | 29.97% | 29.35% | 28.31% | 27.28% | 29.28% | 31.07% | 30.55% | 30.08% | 31.51% | 31.38% |
| Earnings before Tax (EBT) | 236 | - | 287 | 282 | 111 | 235 | 254 | 80 | 104 | - | - | - | - | - | - |
| Net income | 202 | - | 234 | 227 | 108 | 177 | 242 | 58 | 546 | - | - | - | - | - | - |
| Net margin | 12.59% | - | 14.76% | 14.77% | 7.27% | 11.51% | 15.05% | 3.82% | 34.17% | - | - | - | - | - | - |
| EPS | 0.7900 | 1.360 | 0.9200 | 0.8900 | 0.4200 | 0.6900 | 0.9500 | 0.2300 | 2.130 | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | 0.2800 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/17/22 | 5/5/22 | 8/4/22 | 11/3/22 | 2/16/23 | 5/4/23 | 8/8/23 | 11/2/23 | 2/15/24 | 5/2/24 | - | - | - | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 8,397 | 8,207 | 8,067 | 7,644 | 6,929 | 6,144 |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 3.53 x | 3.936 x | 4.15 x | 3.719 x | 3.292 x | 2.851 x |
| Free Cash Flow 1 | - | 1,968 | 662 | 548 | 797 | 1,050 | 1,121 |
| ROE (net income / shareholders' equity) | - | 67.9% | - | - | 405% | 118% | 68.2% |
| ROA (Net income/ Total Assets) | - | 13% | 11.9% | 9.22% | 9.65% | 9.49% | 9.54% |
| Assets 1 | - | 10,395 | 7,726 | 11,094 | 7,786 | 10,232 | 11,229 |
| Book Value Per Share 2 | - | - | -3.500 | -0.2700 | 2.000 | 5.000 | 8.500 |
| Cash Flow per Share 2 | - | 8.500 | 3.360 | 3.120 | 4.430 | 5.170 | 5.610 |
| Capex 1 | - | 192 | 196 | 51 | 215 | 227 | 229 |
| Capex / Sales | - | 3.05% | 3.17% | 0.81% | 3.36% | 3.51% | 3.5% |
| Announcement Date | 4/14/21 | 2/17/22 | 2/16/23 | 2/15/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
21.8
USD
Average target price
22.5
USD
Spread / Average Target
+3.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +51.18% | 5.61B | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- OGN Stock
- Financials Organon & Co.
